ArticleJournal of neurosurgery. Case lessons2026
Primary intraosseous anastomosing hemangioma of the sacrum: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnastomosing hemangioma (AH) is a rare benign vascular neoplasm recognized as a distinct entity in the 2020 WHO classification of soft tissue and bone tumors. Although primarily described in soft tissue and visceral organs, intraosseous AH is exceedingly rare and, to the authors' knowledge, primary sacral involvement has not been previously reported. OBSERVATIONS: A 79-year-old woman presented with progressive sacral pain. MRI revealed a large, T2-hyperintense, heterogeneously enhancing sacral mass (60.2 × 48.5 × 39.8 mm) with osteolytic changes and focal cortical thinning, initially suspected to represent a malignant tumor. PET/CT demonstrated fluorodeoxyglucose uptake (maximum standardized uptake value 3.8). Preoperative transarterial embolization was performed to mitigate hemorrhagic risk. Gross-total resection under microscopic visualization with spinopelvic reconstruction was achieved. Histopathological examination revealed anastomosing capillary-sized vascular channels lined by flat to hobnail endothelial cells, with immunoreactivity for CD31 and CD34, confirming the diagnosis of AH. LESSONS: Sacral intraosseous AH may closely mimic aggressive neoplasms including chordoma, giant cell tumor, and metastasis, posing a significant diagnostic challenge. Accurate diagnosis requires histopathological confirmation. Preoperative embolization may facilitate safe resection by reducing intraoperative bleeding in hypervascular sacral tumors. https://thejns.org/doi/10.3171/CASE26302.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.